Press Release: Advanced Cancer Therapeutics : Advanced Cancer Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) Advanced Cancer Therapeutics (ACT) is a biotechnology company. The company discovers and develops novel cancer therapeutics. Its products include ACT-GRO-777, PU27, PFKFB3, choline kinase and human papillomavirus vaccine. ACT provides ACT-GRO-777 which is an aptamer that binds to a protein called nucleolin on the surface of many cancer cells, which cause the death of cancer cells. The company offers products for the treatment of leukemia, prostate cancer, renal cancer and breast cancer. It also conducts open label, dose escalation, multicenter clinical trial for patients with advanced solid tumors. ACT is headquartered in Louisville, Kentucky, the US. Advanced Cancer Therapeutics - Pharmaceuticals ..